Finnhub
Unlocking the Potential of Treating Cancers That Involve the PI3K/AKT/mTOR Pathway June 2025 ...
Yahoo
• In the Phase 1 portion of the CELC-G-201 clinical trial evaluating gedatolisib plusdarolutamide in men with metastatic castration resistant prostate cancer (“mCRPC”),the six-month radiographic progression free survival (“rPFS”) rate was 66% • In a Phase 2 clinical trial of gedatolisib plus trastuzumab-pkrb as 3L+ therapy in patients with HER2+ metastatic breast cancer (“mBC”), the objective response rate (“ORR”) was 43% • No patients discontinued gedatolisib due to a treatment-related adverse
Finnhub
Celcuity Inc. announced preliminary clinical data for gedatolisib in two early phase clinical trials. In the Phase 1 portion of a clinical trial evaluating gedatolisib plus Nubeqa®? , an approved...
SeekingAlpha
Baker Brothersâ Q1 2025 portfolio reveals biotech investment trends. See more on their top holdings, stake changes, and high-conviction strategies.
Finnhub
Code of Page 1 of 40 Ethical Business Conduct March 2025 ...
Finnhub
Unlocking the Potential of Treating Cancers That Involve the PI3K/AKT/mTOR Pathway May 2025 ...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DNLI | 47.81% | $2.05B | -39.28% | 0.00% |
RXRX | 47.80% | $2.04B | -32.93% | 0.00% |
BEAM | 47.62% | $1.69B | -28.30% | 0.00% |
NRIX | 47.54% | $887.38M | -44.23% | 0.00% |
CLDX | 47.44% | $1.35B | -45.18% | 0.00% |
ATXS | 47.23% | $314.34M | -38.79% | 0.00% |
IMNM | 47.18% | $763.10M | -27.52% | 0.00% |
CRNX | 46.72% | $2.81B | -33.11% | 0.00% |
COGT | 46.61% | $808.38M | -15.78% | 0.00% |
IDYA | 46.48% | $1.87B | -39.13% | 0.00% |
CGON | 46.44% | $1.98B | -17.80% | 0.00% |
KYMR | 45.36% | $2.87B | +47.81% | 0.00% |
OCUL | 45.01% | $1.47B | +34.80% | 0.00% |
XENE | 43.48% | $2.49B | -16.90% | 0.00% |
CRSP | 43.30% | $4.10B | -12.07% | 0.00% |
KRYS | 42.61% | $4.01B | -24.37% | 0.00% |
XNCR | 42.26% | $579.33M | -57.00% | 0.00% |
TWST | 42.14% | $2.15B | -27.09% | 0.00% |
ELVN | 42.13% | $1.22B | -11.51% | 0.00% |
RGNX | 41.80% | $422.76M | -28.29% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -37.24% | $165.69M | 0.85% |
BTAL | -37.21% | $296.79M | 1.43% |
TAIL | -32.74% | $99.76M | 0.59% |
IVOL | -18.13% | $351.30M | 1.02% |
SHYM | -16.81% | $349.95M | 0.35% |
AGZ | -16.27% | $614.02M | 0.2% |
MMIT | -15.69% | $1.02B | 0.3% |
DFNM | -14.96% | $1.56B | 0.17% |
FTSD | -14.89% | $231.79M | 0.25% |
BSMW | -14.29% | $107.14M | 0.18% |
XONE | -14.09% | $585.86M | 0.03% |
STPZ | -13.80% | $450.22M | 0.2% |
FMHI | -13.64% | $752.95M | 0.7% |
UTWO | -13.51% | $379.36M | 0.15% |
JMST | -12.77% | $4.06B | 0.18% |
IEI | -12.71% | $15.37B | 0.15% |
MLN | -12.17% | $539.58M | 0.24% |
SPTS | -12.13% | $5.78B | 0.03% |
IBTL | -12.09% | $380.68M | 0.07% |
MMIN | -12.06% | $334.90M | 0.3% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SCMB | 0.02% | $2.04B | 0.03% |
DFCF | 0.08% | $7.08B | 0.17% |
GSY | -0.09% | $2.73B | 0.22% |
IBDT | 0.10% | $2.86B | 0.1% |
KRBN | -0.16% | $163.57M | 0.85% |
PWZ | -0.17% | $738.62M | 0.28% |
CMBS | -0.21% | $445.85M | 0.25% |
AGGY | 0.22% | $783.13M | 0.12% |
SHV | 0.25% | $20.67B | 0.15% |
PYLD | 0.29% | $5.82B | 0.69% |
CGSD | 0.29% | $1.33B | 0.25% |
JSI | -0.29% | $865.43M | 0.49% |
BSCS | -0.29% | $2.62B | 0.1% |
MUST | -0.34% | $438.44M | 0.23% |
PULS | 0.36% | $11.69B | 0.15% |
AGZD | -0.36% | $102.66M | 0.23% |
IBMP | 0.37% | $553.29M | 0.18% |
IBDU | 0.40% | $2.67B | 0.1% |
BWX | 0.44% | $1.53B | 0.35% |
SHAG | 0.55% | $43.02M | 0.12% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 58.20% | $4.95B | 0.35% |
ARKG | 55.85% | $1.05B | 0.75% |
GNOM | 54.88% | $44.21M | 0.5% |
IBB | 52.37% | $5.36B | 0.45% |
IWC | 51.24% | $824.65M | 0.6% |
PBE | 49.72% | $223.16M | 0.58% |
PTH | 49.66% | $100.99M | 0.6% |
ARKK | 47.56% | $6.89B | 0.75% |
IWO | 46.10% | $11.48B | 0.24% |
XPH | 46.03% | $149.79M | 0.35% |
FBT | 45.49% | $1.01B | 0.54% |
BBH | 45.14% | $329.40M | 0.35% |
KOMP | 44.76% | $2.28B | 0.2% |
IWM | 44.35% | $64.00B | 0.19% |
VTWO | 44.31% | $13.29B | 0.07% |
KJUL | 43.88% | $120.75M | 0.79% |
XSW | 43.87% | $492.02M | 0.35% |
BUZZ | 43.81% | $62.35M | 0.76% |
ISCG | 43.02% | $679.06M | 0.06% |
SCHA | 42.76% | $17.26B | 0.04% |
Current Value
$12.921 Year Return
Current Value
$12.921 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
GFI | -<0.01% | $20.47B | +53.49% | 2.38% |
EVRI | 0.05% | $1.24B | +69.40% | 0.00% |
CCI | -0.08% | $43.83B | +3.02% | 5.73% |
THG | -0.11% | $6.02B | +33.53% | 2.12% |
PM | 0.21% | $281.78B | +78.65% | 3.00% |
PGR | -0.23% | $154.76B | +27.10% | 1.86% |
HLN | -0.26% | $46.67B | +25.67% | 1.71% |
CMS | -0.32% | $20.64B | +15.92% | 3.07% |
KO | -0.39% | $302.72B | +10.49% | 2.83% |
AWR | 0.44% | $2.94B | +5.29% | 2.44% |
PRA | 0.45% | $1.17B | +86.82% | 0.00% |
PPC | 0.48% | $10.57B | +30.66% | 0.00% |
KNOP | 0.54% | $219.16M | -27.14% | 1.64% |
PULM | -0.57% | $25.57M | +262.69% | 0.00% |
PPL | 0.58% | $24.81B | +21.37% | 3.18% |
ADC | 0.64% | $7.96B | +16.81% | 4.20% |
CQP | 0.68% | $26.95B | +13.38% | 5.87% |
ELS | -0.68% | $11.75B | -5.63% | 3.98% |
TU | -0.70% | $24.14B | +4.56% | 7.30% |
CNA | 0.74% | $12.58B | +5.21% | 3.87% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NOC | -16.02% | $71.10B | +13.32% | 1.72% |
ED | -15.06% | $35.36B | +9.76% | 3.39% |
CBOE | -14.94% | $23.98B | +34.66% | 1.10% |
CME | -11.13% | $99.01B | +39.76% | 3.87% |
K | -10.30% | $27.41B | +36.96% | 2.88% |
MCK | -10.09% | $90.65B | +24.27% | 0.39% |
VSTA | -8.93% | $342.46M | +40.00% | 0.00% |
DUK | -8.74% | $90.88B | +16.65% | 3.59% |
AWK | -8.70% | $26.90B | +6.78% | 2.27% |
CL | -8.45% | $71.89B | -8.58% | 2.28% |
CHD | -8.42% | $23.34B | -8.58% | 1.22% |
AEP | -8.05% | $54.73B | +16.78% | 3.58% |
EXC | -7.94% | $43.32B | +23.98% | 3.65% |
HUSA | -7.77% | $22.94M | -6.82% | 0.00% |
ACI | -6.67% | $11.95B | +7.29% | 2.54% |
LMT | -6.63% | $107.45B | -1.82% | 2.85% |
SO | -5.53% | $99.90B | +17.18% | 3.20% |
MO | -5.48% | $98.96B | +28.98% | 6.98% |
CCEC | -5.47% | $1.02B | +3.91% | 2.61% |
TEF | -5.45% | $29.29B | +23.28% | 6.30% |